Table 3.
The clinical and pathological characteristics of the 54 ccRCC patients that used for validation
| Clinicopathologic characteristics | N (%) |
|---|---|
| Age | |
| <60 | 31 (57.4) |
| ≥60 | 23 (42.6) |
| Gender | |
| Male | 32 (59.3) |
| Female | 22 (40.7) |
| Tumor stage | |
| T1 | 20 (37.0) |
| T2 | 12 (22.2) |
| T3 | 21 (38.9) |
| T4 | 1 (1.9) |
| Lymph node stage | |
| N0 | 52 (96.3) |
| N1 | 2 (3.7) |
| Pathological stage | |
| Stage I | 22 (40.7) |
| Stage II | 17 (31.5) |
| Stage III | 12 (22.2) |
| Stage IV | 3 (5.6) |
| Histological grade | |
| G1 | 18 (33.3) |
| G2 | 18 (33.3) |
| G3 | 17 (31.5) |
| G4 | 1 (1.9) |
| VHL mutation | |
| No | 42 (77.8) |
| Yes | 12 (22.2) |